Factors associated with death in patients admitted with Ebola virus disease to Ebola Treatment Units in Guinea, Sierra Leone, and Liberia – December 2013 to March 2016 [version 2; peer review: 2 approved]

Background The 2013-2016 West African Ebola Virus Disease (EVD) outbreak resulted in 28,600 cases and 11,300 deaths officially reported to the World Health Organization. Previous studies investigating factors associated with death had conflicting findings, interventions showing promising outcomes ha...

Full description

Saved in:
Bibliographic Details
Main Authors: Ralph W. Jetoh, Ajay M.V. Kumar, Alexandre Delamou, Laura Merson, Prabin Dahal, Gomathi Ramaswamy, Ibrahima Kaba, Benjamin T. Vonhm, Trokon Omarley Yeabah, Anthony D. Harries, Pryanka Relan, Adam C. Levine
Format: Article
Language:English
Published: F1000 Research Ltd 2025-03-01
Series:F1000Research
Subjects:
Online Access:https://f1000research.com/articles/13-672/v2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850235158261661696
author Ralph W. Jetoh
Ajay M.V. Kumar
Alexandre Delamou
Laura Merson
Prabin Dahal
Gomathi Ramaswamy
Ibrahima Kaba
Benjamin T. Vonhm
Trokon Omarley Yeabah
Anthony D. Harries
Pryanka Relan
Adam C. Levine
author_facet Ralph W. Jetoh
Ajay M.V. Kumar
Alexandre Delamou
Laura Merson
Prabin Dahal
Gomathi Ramaswamy
Ibrahima Kaba
Benjamin T. Vonhm
Trokon Omarley Yeabah
Anthony D. Harries
Pryanka Relan
Adam C. Levine
author_sort Ralph W. Jetoh
collection DOAJ
description Background The 2013-2016 West African Ebola Virus Disease (EVD) outbreak resulted in 28,600 cases and 11,300 deaths officially reported to the World Health Organization. Previous studies investigating factors associated with death had conflicting findings, interventions showing promising outcomes had small sample sizes, studies were often single- or dual-country based and most focused on laboratory-confirmed EVD and not on clinically-suspected EVD. We used the Ebola data platform of the Infectious Disease Data Observatory (IDDO) to review individual patient records to assess factors associated with death, and particularly whether there were differences between laboratory-confirmed and clinically-suspected cases. Methods This was a cohort study involving analysis of secondary data in the IDDO database. The study population included all patients classified as having either clinically-suspected or laboratory-confirmed EVD, admitted to 22 Ebola Treatment Units (ETU) in Guinea, Liberia and Sierra Leone between December 2013 and March 2016. Baseline characteristics and treatments were documented along with ETU exit outcomes. Factors associated with death were investigated by multivariable modified Poisson regression. Results There were 14,163 patients, of whom 6,208 (43.8%) were laboratory-confirmed and 7,955 (56.2%) were clinically-suspected. Outcomes were not recorded in 2,889 (20.4%) patients. Of the 11,274 patients with known outcomes, 4,090 (36.3%) died: 2,956 (43.6%) with laboratory-confirmed EVD and 1,134 (18.8%) with clinically-suspected EVD. The strongest risk factor for death was confirmed disease status. Patients with laboratory-confirmed disease had 2.9 times higher risk of death compared to clinically-suspected patients, after adjusting for other co-variables. Other factors significantly associated with death included a higher risk for patients aged ≥60 years and a lower risk for patients in Sierra Leone. Conclusions Although laboratory-confirmed patients admitted to ETUs fared worse than clinically-suspected patients, the latter still had a substantial risk of death and more attention needs to be paid to this group in future EVD outbreaks.
format Article
id doaj-art-b9bf5bf28b824de6b312eead412db7d4
institution OA Journals
issn 2046-1402
language English
publishDate 2025-03-01
publisher F1000 Research Ltd
record_format Article
series F1000Research
spelling doaj-art-b9bf5bf28b824de6b312eead412db7d42025-08-20T02:02:21ZengF1000 Research LtdF1000Research2046-14022025-03-011310.12688/f1000research.149612.2178279Factors associated with death in patients admitted with Ebola virus disease to Ebola Treatment Units in Guinea, Sierra Leone, and Liberia – December 2013 to March 2016 [version 2; peer review: 2 approved]Ralph W. Jetoh0Ajay M.V. Kumar1Alexandre Delamou2Laura Merson3https://orcid.org/0000-0002-4168-1960Prabin Dahal4Gomathi Ramaswamy5Ibrahima Kaba6Benjamin T. Vonhm7Trokon Omarley Yeabah8https://orcid.org/0000-0002-3790-8042Anthony D. Harries9https://orcid.org/0000-0001-6113-9741Pryanka Relan10https://orcid.org/0000-0002-9543-7891Adam C. Levine11Department of Technical Services, National Public Health Institute of Liberia, Monrovia, Montserrado, 1000, LiberiaInternational Union Against Tuberculosis and Lung Disease, The Union, 2 Rue Jean Lantier, Paris, 75001, FranceCentre national de formation et de recherche en santé rurale de Maferinyah, University Gamal Abdel Nasser, Forécariah, Conakry, 1017, GuineaISARIC, Pandemic Sciences Institute, University of Oxford, Old Road Campus, Headington, Oxfordshire, OX3 7LG, UKInfectious Diseases Data Observatory, Centre for Tropical Medicine & Global Health, University of Oxford, Headington, Oxfordshire, OX3 7LG, UKAll India Institute of Medical Sciences, Bibinagar, Hyderabad, 508126, IndiaAfrican Center of Excellence for the Prevention and Control of Transmissible Diseases, University Gamal Abdel Nasser, Conakry, Guinea, 1017, GuineaDepartment of Technical Services, National Public Health Institute of Liberia, Monrovia, Montserrado, 1000, LiberiaDepartment of Technical Services, National Public Health Institute of Liberia, Monrovia, Montserrado, 1000, LiberiaDepartment of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UKHealth Emergencies Programme, World Health Organization, Avenue Appia 20, Geneva, 1203, SwitzerlandWarren Alpert Medical School, Brown University, Providence, Rhode Island, 02903, USABackground The 2013-2016 West African Ebola Virus Disease (EVD) outbreak resulted in 28,600 cases and 11,300 deaths officially reported to the World Health Organization. Previous studies investigating factors associated with death had conflicting findings, interventions showing promising outcomes had small sample sizes, studies were often single- or dual-country based and most focused on laboratory-confirmed EVD and not on clinically-suspected EVD. We used the Ebola data platform of the Infectious Disease Data Observatory (IDDO) to review individual patient records to assess factors associated with death, and particularly whether there were differences between laboratory-confirmed and clinically-suspected cases. Methods This was a cohort study involving analysis of secondary data in the IDDO database. The study population included all patients classified as having either clinically-suspected or laboratory-confirmed EVD, admitted to 22 Ebola Treatment Units (ETU) in Guinea, Liberia and Sierra Leone between December 2013 and March 2016. Baseline characteristics and treatments were documented along with ETU exit outcomes. Factors associated with death were investigated by multivariable modified Poisson regression. Results There were 14,163 patients, of whom 6,208 (43.8%) were laboratory-confirmed and 7,955 (56.2%) were clinically-suspected. Outcomes were not recorded in 2,889 (20.4%) patients. Of the 11,274 patients with known outcomes, 4,090 (36.3%) died: 2,956 (43.6%) with laboratory-confirmed EVD and 1,134 (18.8%) with clinically-suspected EVD. The strongest risk factor for death was confirmed disease status. Patients with laboratory-confirmed disease had 2.9 times higher risk of death compared to clinically-suspected patients, after adjusting for other co-variables. Other factors significantly associated with death included a higher risk for patients aged ≥60 years and a lower risk for patients in Sierra Leone. Conclusions Although laboratory-confirmed patients admitted to ETUs fared worse than clinically-suspected patients, the latter still had a substantial risk of death and more attention needs to be paid to this group in future EVD outbreaks.https://f1000research.com/articles/13-672/v2West Africa Ebola mortality viral haemorrhagic fever filovirus SORT ITeng
spellingShingle Ralph W. Jetoh
Ajay M.V. Kumar
Alexandre Delamou
Laura Merson
Prabin Dahal
Gomathi Ramaswamy
Ibrahima Kaba
Benjamin T. Vonhm
Trokon Omarley Yeabah
Anthony D. Harries
Pryanka Relan
Adam C. Levine
Factors associated with death in patients admitted with Ebola virus disease to Ebola Treatment Units in Guinea, Sierra Leone, and Liberia – December 2013 to March 2016 [version 2; peer review: 2 approved]
F1000Research
West Africa
Ebola
mortality
viral haemorrhagic fever
filovirus
SORT IT
eng
title Factors associated with death in patients admitted with Ebola virus disease to Ebola Treatment Units in Guinea, Sierra Leone, and Liberia – December 2013 to March 2016 [version 2; peer review: 2 approved]
title_full Factors associated with death in patients admitted with Ebola virus disease to Ebola Treatment Units in Guinea, Sierra Leone, and Liberia – December 2013 to March 2016 [version 2; peer review: 2 approved]
title_fullStr Factors associated with death in patients admitted with Ebola virus disease to Ebola Treatment Units in Guinea, Sierra Leone, and Liberia – December 2013 to March 2016 [version 2; peer review: 2 approved]
title_full_unstemmed Factors associated with death in patients admitted with Ebola virus disease to Ebola Treatment Units in Guinea, Sierra Leone, and Liberia – December 2013 to March 2016 [version 2; peer review: 2 approved]
title_short Factors associated with death in patients admitted with Ebola virus disease to Ebola Treatment Units in Guinea, Sierra Leone, and Liberia – December 2013 to March 2016 [version 2; peer review: 2 approved]
title_sort factors associated with death in patients admitted with ebola virus disease to ebola treatment units in guinea sierra leone and liberia december 2013 to march 2016 version 2 peer review 2 approved
topic West Africa
Ebola
mortality
viral haemorrhagic fever
filovirus
SORT IT
eng
url https://f1000research.com/articles/13-672/v2
work_keys_str_mv AT ralphwjetoh factorsassociatedwithdeathinpatientsadmittedwithebolavirusdiseasetoebolatreatmentunitsinguineasierraleoneandliberiadecember2013tomarch2016version2peerreview2approved
AT ajaymvkumar factorsassociatedwithdeathinpatientsadmittedwithebolavirusdiseasetoebolatreatmentunitsinguineasierraleoneandliberiadecember2013tomarch2016version2peerreview2approved
AT alexandredelamou factorsassociatedwithdeathinpatientsadmittedwithebolavirusdiseasetoebolatreatmentunitsinguineasierraleoneandliberiadecember2013tomarch2016version2peerreview2approved
AT lauramerson factorsassociatedwithdeathinpatientsadmittedwithebolavirusdiseasetoebolatreatmentunitsinguineasierraleoneandliberiadecember2013tomarch2016version2peerreview2approved
AT prabindahal factorsassociatedwithdeathinpatientsadmittedwithebolavirusdiseasetoebolatreatmentunitsinguineasierraleoneandliberiadecember2013tomarch2016version2peerreview2approved
AT gomathiramaswamy factorsassociatedwithdeathinpatientsadmittedwithebolavirusdiseasetoebolatreatmentunitsinguineasierraleoneandliberiadecember2013tomarch2016version2peerreview2approved
AT ibrahimakaba factorsassociatedwithdeathinpatientsadmittedwithebolavirusdiseasetoebolatreatmentunitsinguineasierraleoneandliberiadecember2013tomarch2016version2peerreview2approved
AT benjamintvonhm factorsassociatedwithdeathinpatientsadmittedwithebolavirusdiseasetoebolatreatmentunitsinguineasierraleoneandliberiadecember2013tomarch2016version2peerreview2approved
AT trokonomarleyyeabah factorsassociatedwithdeathinpatientsadmittedwithebolavirusdiseasetoebolatreatmentunitsinguineasierraleoneandliberiadecember2013tomarch2016version2peerreview2approved
AT anthonydharries factorsassociatedwithdeathinpatientsadmittedwithebolavirusdiseasetoebolatreatmentunitsinguineasierraleoneandliberiadecember2013tomarch2016version2peerreview2approved
AT pryankarelan factorsassociatedwithdeathinpatientsadmittedwithebolavirusdiseasetoebolatreatmentunitsinguineasierraleoneandliberiadecember2013tomarch2016version2peerreview2approved
AT adamclevine factorsassociatedwithdeathinpatientsadmittedwithebolavirusdiseasetoebolatreatmentunitsinguineasierraleoneandliberiadecember2013tomarch2016version2peerreview2approved